Editorial Comment on “Safety of Partial and Radical Nephrectomy for Complex Locally Advanced Renal Cell Carcinoma After Neo-Adjuvant Immune Checkpoint Inhibition—Analysis From a Phase 1b Trial (Durvalumab +/- Tremelimumab)”

Posted by author-avatar

Publication date: October 2025

Source: Urology, Volume 204

Author(s): Matthew S. Lee, Abhinav Khanna

Read More

Newer
Safety of Partial and Radical Nephrectomy for Complex Locally Advanced Renal Cell Carcinoma After Neo-Adjuvant Immune Checkpoint Inhibition: Analysis From a Phase 1b Trial (Durvalumab +/- Tremelimumab)
Older Development and External Validation of a Local Pelvic Recurrence Risk Score After Radical Cystectomy: Identifying the Ideal Candidate for Adjuvant Radiation Clinical Trials